Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Axogen Inc (AXGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 841,212
  • Shares Outstanding, K 38,945
  • Annual Sales, $ 83,940 K
  • Annual Income, $ -22,400 K
  • 60-Month Beta 0.20
  • Price/Sales 10.05
  • Price/Cash Flow N/A
  • Price/Book 6.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.19
  • Number of Estimates 3
  • High Estimate -0.18
  • Low Estimate -0.20
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.48 +7.88%
on 05/20/19
25.84 -18.69%
on 05/03/19
+0.36 (+1.74%)
since 04/23/19
3-Month
15.00 +40.07%
on 02/27/19
25.84 -18.69%
on 05/03/19
+3.05 (+16.98%)
since 02/22/19
52-Week
14.13 +48.69%
on 01/09/19
56.85 -63.04%
on 07/24/18
-23.74 (-53.05%)
since 05/23/18

Most Recent Stories

More News
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of -7.14% and 4.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

AXGN : 21.01 (-2.73%)
Axogen, Inc. Reports 2019 First Quarter Financial Results

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today reported financial results and business highlights...

AXGN : 21.01 (-2.73%)
Axogen, Inc. Appoints New Members to Board of Directors

Quentin S. Blackford, Executive Vice President and Chief Financial Officer of Dexcom

AXGN : 21.01 (-2.73%)
Axogen, Inc. to Report First Quarter 2019 Financial Results and Host Conference Call on May 8, 2019

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report first quarter...

AXGN : 21.01 (-2.73%)
Robbins Arroyo LLP: AxoGen, Inc. (AXGN) Misled Shareholders According to Class Action

Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of AxoGen, Inc. (NASDAQ: AXGN) filed a class action complaint against the company for alleged violations...

AXGN : 21.01 (-2.73%)
AXOGEN 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit against AxoGen, Inc. - AXGN

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until March...

AXGN : 21.01 (-2.73%)
KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder for AXOGEN, INC. Investors - AXGN

Kessler Topaz Meltzer & Check, LLP reminds AxoGen, Inc. (Nasdaq: AXGN) ("AxoGen") investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Middle...

AXGN : 21.01 (-2.73%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AxoGen, Inc. - AXGN

Pomerantz LLP is investigating claims on behalf of investors of AxoGen, Inc. ("AxoGen or the "Company") (NASDAQ: AXGN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

AXGN : 21.01 (-2.73%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AXGN, ATVI, CTL and INGN

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

AXGN : 21.01 (-2.73%)
ATVI : 42.19 (-1.68%)
CTL : 9.66 (-3.01%)
INGN : 66.11 (-2.87%)
(AXGN) AxoGen, Inc. - Bronstein, Gewirtz & Grossman, LLC Announces Deadline - March 11, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against AxoGen, Inc. ("AxoGen" or the "Company") (NASDAQ: AXGN) and certain of its...

AXGN : 21.01 (-2.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade AXGN with:

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

2nd Resistance Point 21.66
1st Resistance Point 21.34
Last Price 21.01
1st Support Level 20.71
2nd Support Level 20.40

See More

52-Week High 56.85
Fibonacci 61.8% 40.53
Fibonacci 50% 35.49
Fibonacci 38.2% 30.45
Last Price 21.01
52-Week Low 14.13

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar